The FDA has started a priority review of AstraZeneca's IL-33-targeting antibody tozorakimab for chronic obstructive pulmonary ...
An Indiana 3-year-old died after a mucus plug blocked his tracheostomy tube, with his mom alleging in a lawsuit that the ...
An Indiana 3-year-old died after a mucus plug blocked his tracheostomy tube, with his mom alleging in a lawsuit that the ...
The Biologics License Application for tozorakimab 300mg, administered once every four weeks, has been accepted for Priority Review by the US Food and Drug Administration as an add-on maintenance ...
At ERS 2026, AstraZeneca presented new Phase III data on the impact of tozorakimab versus placebo on mucus plugs in patients with COPD.
AstraZeneca announced that full results from the positive Phase III OBERON and TITANIA trials showed that tozorakimab is the first biologic to demonstrate statistically significant and highly ...
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a ...
Bharti Yoga on MSN
6 signs your body may be getting ready for labor
In your 9th month and wondering when labor might start? 👀 Here are some common signs that your body may be getting ready, from period-like cramps and increased pelvic pressure to losing your mucus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results